⚡ عاجل: كريستيانو رونالدو يُتوّج كأفضل لاعب كرة قدم في العالم●⚡ أخبار عاجلة تتابعونها لحظة بلحظة على خبر●⚡ تابعوا آخر المستجدات والأحداث من حول العالم●
AI اقتراحات ذكية
AI مباشر|--مشاهد مباشر
865,947مقال404مصدر نشط228قناة مباشرة5,618خبر اليوم
آخر تحديث:منذ ثانيتين
New obesity pill approved in UAE: Who can get it, availability, prescription explained
UAE residents may soon have access to a new weight-loss treatment that does not require injections; however, doctors have said that the recently approved oral obesity pill is not for everyone and will be prescribed under strict medical supervision.
The Emirates Drug Establishment (EDE) approved Foundayo (orforglipron), a once-daily oral medication for chronic weight management, making the UAE one of the first countries to register the treatment.
The approval comes amid a global shift towards pill-based therapies, after the US Food and Drug Administration also approved an oral version of semaglutide, sold as Wegovy by Novo Nordisk.
Doctors said that the treatment will be prescribed to adults with obesity, defined as a body mass index (BMI) of 30 or above, or those who are overweight (BMI above 27) with at least one related health condition.
“These include conditions such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnea or joint-related issues,” said Dr Noor Naji, HOD and consultant internal medicine, Burjeel Medical City.
Dr Noor Naji
According to doctors, the medication may also be considered for patients who have not achieved weight loss through lifestyle changes alone.
Is it only for obesity?
No. Doctors said it can also be prescribed to overweight patients, but only if they have weight-related medical conditions.
Dr Manish Madnani, specialist gastrointestinal surgeon at NMC Specialty Hospital, Al Nahda, Dubai, said that eligibility follows a simple rule: “BMI of 30 or more, or BMI above 27 with associated health issues.”
Dr Manish Madnani
Will a specialist be required?
Yes. Doctors said the medication will typically be prescribed by specialists, at least in the initial stages. “It is recommended to be prescribed by an endocrinologist, obesity specialist or internal medicine specialist,” said Dr Nassim Y Salamin, consultant internal medicine, Medcare Medical Centre.
He added that specialists are better equipped to assess patient history, identify contraindications, and monitor for side effects.
Dr Nassim Y Salamin
What tests are needed before starting?
Patients will need a proper medical evaluation before starting the medication.
This includes:
Weight and BMI assessment
Blood sugar levels
Lipid profile
Liver, kidney and thyroid function tests
Detailed personal and family medical history
Doctors said additional tests may be required depending on individual conditions.
Who should avoid the treatment?
The medication is not suitable for everyone.
Doctors said it should be avoided by:
Patients with a personal or family history of certain thyroid cancers
Those with specific endocrine disorders such as MEN-2
Pregnant or breastfeeding women
“Patients with severe gastrointestinal conditions, kidney issues, or previous adverse reactions to similar drugs may also need careful evaluation,” said Dr Nassim.
How long will treatment last?
This is not a short-term solution. Doctors said that treatment could be long-term, and in some cases lifelong, depending on the patient’s condition and response.
“Patients are likely to continue treatment as long as it provides benefits and is well tolerated. Stopping the medication without maintaining lifestyle changes may lead to weight regain,” said Dr Noor Naji.
Will diet and exercise still be needed?
Yes, and doctors said that this is critical.
Doctors highlighted that the medication is meant to support lifestyle changes, not replace them. “Patients will still need to follow a structured diet and maintain regular physical activity to achieve and sustain weight loss,” said Dr Manish Madnani.
When will it be available?
The new oral treatment is expected to become available to eligible patients in the UAE starting May 2026.
While the pill offers a more convenient alternative to injections, doctors emphasised that its use will depend on proper medical evaluation and a long-term commitment to treatment and lifestyle changes.
ملاحظة تحريرية | Editorial Note:
نُشر هذا المقال في الأصل بواسطة Khaleej Times.
خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي.
نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق.
هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Khaleej Times.
Khabr is a licensed Jordanian AI-powered news platform (Registration #82086).
We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking.
Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
هذا الخبر ضمن تغطية خبر لقسم ترفيه.
نقدّم لك تحليلات ذكية وملخصات يومية لأهم الأخبار من مصادر موثوقة متعددة.
المصدر: Khaleej Times.
يوجد 6 مقالات مرتبطة بهذا الموضوع.
This article is part of Khabr's coverage of Entertainment.
We provide AI-powered analysis, summaries, and multi-source aggregation to keep you informed.
Source: Khaleej Times.
Tags: Broadway, theater, review.
🍪 نستخدم ملفات تعريف الارتباط لتحسين تجربتك وعرض الإعلانات المخصصة. باستخدامك للموقع، فإنك توافق على سياسة ملفات تعريف الارتباط وسياسة الخصوصية.
We use cookies to enhance your experience and show personalized ads. By using this site, you agree to our Cookie Policy and Privacy Policy.
FREEFree 1GB Internet + Free International Calls
$1 trial — eSIM in 190+ countries — No roaming charges